Bacillus strains as human probiotics: characterization, safety, microbiome, and probiotic carrier
Top Cited Papers
- 8 October 2019
- journal article
- research article
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 28 (5) , 1297-1305
Abstract
Both spore and vegetative forms of Bacillus species have been used as probiotics, and they have high stability to the surrounding atmospheric conditions such as heat, gastric conditions, and moisture. The commercial Bacillus probiotic strains in use are B. cereus, B. clausii, B. coagulans, B. licheniformis, B. polyfermenticus, B. pumilus, and B. subtilis. These strains have antimicrobial, anticancer, antioxidant, and vitamin production properties. However, Bacillus probiotics can also produce toxins and biogenic amines and transfer antibiotic resistance genes; therefore, their safety is a concern. Studies on the microbiome using probiotic Bacillus strains are limited in humans. Most microbiome research has been conducted in chicken, mouse, and pig. Some Bacillus probiotics are used as fermentation starters in plant and soybean and dietary supplement of baking foods as a probiotic carrier. This review summarizes the characterization of Bacillus species as probiotics for human use and their safety, microbiome, and probiotic carrier.Keywords
This publication has 72 references indexed in Scilit:
- Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organTherapeutic Advances in Gastroenterology, 2013
- Prevalence, phenotypic traits and molecular characterization of emetic toxin-producing Bacillus cereus strains isolated from human stools in KoreaJournal of Applied Microbiology, 2012
- Development of a screening method for biogenic amine producing Bacillus spp.International Journal of Food Microbiology, 2012
- Control of Biogenic Amines in Food—Existing and Emerging ApproachesJournal of Food Science, 2010
- Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trialBMC Complementary and Alternative Medicine, 2010
- Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredientFood and Chemical Toxicology, 2009
- The safety ofBacillus subtilisandBacillus indicusas food probioticsJournal of Applied Microbiology, 2008
- Efficacy ofBacillus clausiispores in the prevention of recurrent respiratory infections in children: a pilot studyTherapeutics and Clinical Risk Management, 2007
- Bacillus cereus and its food poisoning toxinsFEMS Microbiology Letters, 2006
- Multiplex PCR for colony direct detection of Gram-positive histamine- and tyramine-producing bacteriaJournal of Microbiological Methods, 2005